Kari L. Olson, PharmD

home / authors / kari-l-olson-pharmd

Articles

July 13th 2011

Systolic Blood Pressure Control After Participation in a Hypertension Intervention Study

Lesley K. Welch, PharmD Kari L. Olson, PharmD Karen E. Snow, Lauren Pointer, MS Anne Lambert-Kerzner, MSPH Edward P. Havranek, MD David J. Magid, MD, MPH P. Michael Ho, MD, PhD

Systolic blood pressure control was not maintained in a large proportion of patients after the end of participation in a hypertension intervention study.

October 8th 2009

Statin Adherence and Mortality in Patients Enrolled in a Secondary Prevention Program

Brandy D. McGinnis, PharmD Kari L. Olson, PharmD Thomas M. A. Delate, PhD Ryan S. Stolcpart, PharmD

Enrollment in a secondary disease prevention program can have a significant impact on statin adherence and subsequent clinical outcomes.

August 7th 2009

Outcomes of Patients Discharged From Pharmacy-Managed Cardiovascular Disease Management

Kari L. Olson, PharmD Thomas Delate, PhD Jon Rasmussen, PharmD Tammy L. Humphries, PharmD John A. Merenich, MD for the Clinical Pharmacy Cardiac Risk Service Study Group

Lipid levels can remain controlled with electronic laboratory reminder letters for most patients with coronary artery disease discharged from a cardiovascular disease management program.